Characterization of virus-like particles in GARDASIL® by cryo transmission electron microscopy. [PDF]
Zhao Q +9 more
europepmc +1 more source
Immunogenicity and safety of prophylactic HPV vaccines in people living with HIV: A systematic review and meta-analysis. [PDF]
Senel B, Senel G, Elma C.
europepmc +1 more source
HPV vaccine is safe \u2014 (Gardasil)
HPV vaccines protect against certain cancers caused by human papillomavirus (HPV) infection. HPV infection can cause cervical, vaginal, and vulvar cancers in women and penile cancer in men.
core
Veil-Based Collector Device Enabling Self-Collected Cervicovaginal Sampling for Site-of-Care Primary HPV-Based Cervical Cancer and Sexually Transmitted Infections Screening: A Pilot Feasibility Study in Romania. [PDF]
Ciuhodaru M +11 more
europepmc +1 more source
Development of a 12-Valent HPV L1 Virus-like Particle Vaccine Using an Enhanced Baculovirus Expression System. [PDF]
Kim JD +10 more
europepmc +1 more source
Economic Evaluations of New Vaccine Introduction in Middle-Income Countries in the Middle East and North Africa Region: A Systematic Review. [PDF]
Bishop C +7 more
europepmc +1 more source
Memory B-cells elicited by different HPV vaccine regimens in the DoRIS randomised controlled trial. [PDF]
Wiggins R +20 more
europepmc +1 more source
Integrating Adjuvant HPV Vaccination into Cervical Dysplasia Management After LLETZ/Conization. [PDF]
Anton ET +9 more
europepmc +1 more source
New HPV Vaccines on the Market and Future Trends: A State-of-the-Art Review. [PDF]
Akgör U +5 more
europepmc +1 more source

